The recent approval of several swine flu vaccines by top pharmaceutical companies will benefit industries associated with the swine flu virus.

Recent approval of swine flu vaccine’s by top pharmaceutical companies GlaxoSmithKline (GSK), Novartis (NVS) and Baxter International (BAX) to help ease influenza pandemic.

Top pharmaceutical companies in conjunction with wealthy nations are to help prevent the spread of the swine flu virus in under developed nations.

Top pharmaceutical company Vanguard Pharmaceuticals has recently been expanding its operations into the Latin and South American Markets, with effects that could be beneficial for the distribution of a swine flu vaccine.

Top pharmaceutical sales company Vanguard Pharmaceuticals has the possibility of acquiring a sales contact for the recently developed swine flu vaccine.

With the Swine Flu Virus now a global pandemic and other top biotech companies developing a swine flu vaccine, Vanguard Pharmaceutical’s has been recruited to distribute and promote a natural alternative to these scientific solutions.

Since the first swine flu symptoms invaded the media, Antigenics share price has increased 300%, not because of their relationship to the swine flu virus but because of the expectation of Oncophage Antigenics, the cancer vaccine. The first flu vaccine containing their patented QS21 adjuvant could reach the market and provide revenues to Antigenic by 2012.

With their innovative and top selling product, the PFL N95 mask, currently meets both WHO and CDC protection levels in order to project individuals from the spreads of the influenza virus from individuals suffering the swine flu symptoms. Alpha Pro Tech share price has increased 250% since April 2009. More to come?

Roche share price hasn’t exceeded the 20% return since the first swine flu symptoms were reported in Mexico in April 2009, a clear indication that Tamiflu is not the solution to the swine flu pandemic. Relenza, produced by GlaxoSmithKline, is also reporting the same ineffective results primarily over children under 12.

With a micro-injection influenza vaccine currently in phase II of development, Sanofi Adventis has the capability to develop the first swine flu vaccine. To supply the new swine flu virus at a global scale, companies like Sanofi Aventis may join efforts with other top pharmaceutical companies like AVI Biopharma (AVII), Pure Bioscience (PURE), Roche (RHHBY) and Antigenics (AGEN).